Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_assertion description "[NAT2 slow acetylator genotypes (NAT2 *5, NAT2 *6, NAT2 *7) significantly increased the risk of esophageal squamous cell carcinoma (ESCC, OR=1.73; 95% CI=1.01-2.97; p=0.047).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_assertion evidence source_evidence_literature NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_assertion SIO_000772 19766908 NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_assertion wasDerivedFrom befree-20140225 NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_assertion wasGeneratedBy ECO_0000203 NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.
- befree-20140225 importedOn "2014-02-25" NP628082.RA5E1LVYs_tlsn-xXu8CVRrCpTLAbGZGf31kLt347Iw88130_provenance.